Sec Form 4 Filing - MANOGUE CAROLINE B @ ENDO HEALTH SOLUTIONS INC. - 2013-08-26

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
MANOGUE CAROLINE B
2. Issuer Name and Ticker or Trading Symbol
ENDO HEALTH SOLUTIONS INC. [ ENDP]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
Exec. V.P., CLO & Secy
(Last) (First) (Middle)
C/O ENDO HEALTH SOLUTIONS INC., 1400 ATWATER DRIVE
3. Date of Earliest Transaction (MM/DD/YY)
08/26/2013
(Street)
MALVERN, PA19355
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value, $.01 per share 08/26/2013 M 130,000 A $ 28.61 192,014 ( 1 ) D
Common Stock, par value, $.01 per share 08/26/2013 S 130,000 D $ 39.4 ( 2 ) 62,014 ( 1 ) D
Common Stock, par value, $.01 per share 08/26/2013 S 15,592 D $ 39.4 ( 2 ) 46,422 ( 1 ) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
2004 Stock Incentive Plan Stock Options (NQ) $ 28.61 08/26/2013 M 130,000 ( 3 ) 02/14/2016 Common Stock 130,000 $ 0 ( 4 ) 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MANOGUE CAROLINE B
C/O ENDO HEALTH SOLUTIONS INC.
1400 ATWATER DRIVE
MALVERN, PA19355
Exec. V.P., CLO & Secy
Signatures
/s/ Caroline B. Manogue 08/28/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )On August 9, 2013, in connection with her personal financial planning, Ms. Manogue placed 130,000 of the shares underlying her stock options and 15,592 shares of common stock, which she had obtained upon vesting of certain restricted stock units and performance share units, into a 10b5-1 pre-set selling program (the "Manogue Pre-Set Selling Program"). The Manogue Pre-Set Selling Program's initial termination date was the earlier of August 29, 2014 or the date all shares under the program were sold. The options exercised and the shares sold above were sold pursuant to the Manogue Pre-Set Selling Program, which leaves no remaining shares (underlying options or otherwise) in the current Manogue Pre-Set Selling Program.
( 2 )This represents the price at which Ms. Manogue's common shares were sold on August 26, 2013.
( 3 )Ms. Manogue's stock options that were granted under the 2004 Stock Incentive Plan on February 14, 2006 were generally exercisable 25% per year on each of February 14, 2007, February 14, 2008, February 14, 2009, February 14, 2010.
( 4 )These securities were granted to Ms. Manogue in 2006 in consideration of her services as the Executive Vice President, Chief Legal Officer and Secretary of Endo Health Solutions Inc.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.